Leaflet TRINOMIA 100mg / 20mg / 10mg capsules

Product code:
W60815003
Quantity:
28
Indicated for:
cardiovascular prevention
Route of administration:
oral
Substance:
acetylsalicylic acid + atorvastatin + ramipril (antiplatelet agent + statin lipid-lowering agent + ACE inhibitor)
ATC
C10BX06 — Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs

Precautions:

Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Avoid grapefruit

Avoid grapefruit and grapefruit juice.

Hepatotoxicity

This medicine may affect the liver.

Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions

This medicine may have important interactions with other medicines.

Myopathy / rhabdomyolysis

Seek medical advice if unexplained muscle pain occurs.

Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Nephrotoxicity

This medicine may affect the kidneys.

Pediatric warning

Use in children only as recommended in the leaflet or by a doctor.

Bleeding risk

This medicine may increase the risk of bleeding.

Electrolyte disturbances

This medicine may change blood electrolyte levels.

Ulcer / gastrointestinal bleeding

This medicine may increase the risk of ulcer or gastrointestinal bleeding.

Acetylsalicylic acid + atorvastatin + ramipril is a combination of medications used for the prevention and treatment of cardiovascular diseases, particularly in patients at high risk of myocardial infarction, stroke, or other cardiovascular complications.

- Acetylsalicylic acid (aspirin) is an antiplatelet agent that prevents blood clot formation, reducing the risk of thrombotic events.
- Atorvastatin is a statin that lowers LDL cholesterol ('bad cholesterol') and triglycerides, helping to prevent atherosclerosis.
- Ramipril is an angiotensin-converting enzyme inhibitor (ACE inhibitor) that lowers blood pressure, protects the heart and kidneys, and reduces the risk of heart failure.

This combination is particularly indicated for patients with hypertension, dyslipidemia, and a history of cardiovascular diseases.

Side effects may include gastric irritation, nausea, dizziness, muscle pain (atorvastatin), or dry cough (ramipril). Regular monitoring of liver function, kidney function, and lipid profile is important for patients on this therapy.

This combination is contraindicated in patients with allergies to any of the components, severe liver impairment, advanced kidney failure, or bleeding disorders. Consult your doctor before use, especially if you are taking other anticoagulant or antihypertensive medications.

General data about TRINOMIA 100mg / 20mg / 10mg

Substance:
acetylsalicylic acid + atorvastatin + ramipril
Date of latest medicines list:
01-03-2022
Product code:
W60815003
Concentration:
100mg / 20mg / 10mg
Pharmaceutical form:
capsules
Quantity:
28
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
FERRER INTERNACIONAL, S.A. - SPANIA
Holder:
FERRER INTERNACIONAL, S.A. - SPANIA
Number:
11523/2019/03
Shelf life:
2 years

Concentrations available for acetylsalicylic acid + atorvastatin + ramipril

  • 100mg/20mg/10mg
  • 100mg/20mg/2.5mg
  • 100mg/20mg/5mg
  • 100mg/40mg/10mg
  • 100mg/40mg/2.5mg
  • 100mg/40mg/5mg